STOCKHOLM, Aug. 22, 2017 /PRNewswire/ -- The Swedish-American Life Science Summit (SALSS) announced today that this year's conference will focus on Joe Biden's Cancer Moonshot, including perspectives of living with chronic disease, HealthTech Transformation, that is increasingly driven also by Technology companies and Patients, and how Impact Investing and other alternative Financing can change the business of Life Science.
From the start SALSS is meant to serve as a business platform, but also to provide insights to the future of Life Science and initiate new ideas and collaborations. "This year, I'm exited to feature so many bright and accomplished women from diverse backgrounds in the industry. To secure the future of Life Science we need to support and grow all the talent and diversity available in this field," says Barbro C. Ehnbom, Founder and Chairman.
"We can never put boundaries on innovation. SALSS brings together the diverse life sciences community the world over to collaborate, exchange ideas and share knowledge," says Dr. Bahija Jallal, Head MedImmune, Executive Vice President, AstraZeneca.
The impressive list of speakers this year features among others Gregory Simon, President of Biden Cancer Initiative, Dr. Bahija Jallal, Head of MedImmune, Canan Dagdeviren, Associate Professor, Wearable Electronics, MIT Media Lab, Christer Fugelsang, Professor, Royal Institute of Technology and Astronaut, Mouna Esmaeilzadeh, Founder of SciLife Clinic, Maria Strømme, Professor Nanotechnology, Uppsala University, Dr. Laurent Leksell, Chairman of Elekta and Hans Stråberg, Chairman of Atlas Copco.
ABOUT SALSS 2017 The Swedish-American Life Science Summit 2017 is the 13th annual Summit in an invitation-only format, with a program featuring some of the best known Life Science scientists, executives and investors in the world. The objective is to stimulate the Life Science sector in Sweden, paving the way for new investments and establishing Sweden as an international hub for Life Science. The Summit program includes panel discussions, keynote speeches and company presentations. Barbro C. Ehnbom, Founder and Chairman of SALSS, has been a pioneer in the Life Science industry throughout her whole career and is passionate about seeing the Swedish Life Science Sector prosper in collaboration with the global business world.
For more information on SALSS, visit www.salss.com.
View original content:http://www.prnewswire.com/news-releases/the-13th-swedish-american-life-science-summit-taking-place-in-stockholm-sweden-august-23-25-will-focus-on-cancer-moonshot-healthtech-transformation-and-impact-investing-300508114.html
SOURCE Swedish-American Life Science Summit